A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience

Sadeleştirilmiş öğe sayfası
dc.contributor.authorDikmen, Pinar Yalinay
dc.contributor.authorKosak, Seda
dc.contributor.authorAydinlar, Elif Ilgaz
dc.contributor.authorKocaman, Ayse Sagduyu
dc.date.accessioned2025-10-16T15:25:12Z
dc.date.issued2018
dc.identifier.doi10.1007/s13760-018-0978-9
dc.identifier.otherWOS:000442249600018
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8219
dc.publisherSPRINGER HEIDELBERG
dc.sourceACTA NEUROLOGICA BELGICA
dc.subjectMigraine
dc.subjectMIDAS
dc.subjectOnabotulinumtoxinA
dc.subjectCompliance
dc.subjectChronic migraine
dc.titleA single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS